GlassScriptPhysician profile
Eihab Akary
NPI 1144640855
$5,193.61
in general payments reported to CMS, 2019-2025
26 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $312 · 2021: $359 · 2022: $1,539 · 2023: $949 · 2024: $167 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,071 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,071.30 |
| Travel and Lodging | $246.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,417.48 | 2021-2025 | Urolift, Barrigel |
| Coloplast Corp | $578.75 | 2019-2023 | Titan |
| Boston Scientific Corporation | $486.68 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Superion Indirect Decompression System |
| Endo Pharmaceuticals INC. | $417.33 | 2020-2024 | Aveed, Xiaflex, Edex |
| Neotract INC. | $188.99 | 2019-2020 | |
| Dornier Medtech America, INC | $167.26 | 2023 | Dornier Medtech |
| Medtronic USA, INC. | $123.28 | 2020 | |
| Allergan, INC. | $105.86 | 2019-2021 | |
| Janssen Biotech, INC. | $91.65 | 2019-2022 | |
| Astellas Pharma US INC | $81.62 | 2019-2023 | Myrbetriq |
| Laborie Medical Technologies Corp. | $58.06 | 2023-2025 | |
| Pfizer INC. | $57.50 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $54.37 | 2023 | Lynparza, Keytruda |
| 180 Medical, INC. | $52.57 | 2021-2022 | |
| Antares Pharma, INC. | $43.57 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $40.79 | 2023 | |
| Abbvie INC. | $40.24 | 2022-2023 | Botox |
| Urogen Pharma, INC. | $38.08 | 2025 | |
| Profound Medical Corp. | $24.44 | 2023 | Tulsa-Pro |
| Becton, Dickinson and Company | $21.88 | 2024 | Arista Ah Flexitip |
| Blue Earth Diagnostics | $21.24 | 2023 | |
| Sumitomo Pharma America, INC. | $18.49 | 2024 | Orgovyx |
| Ge Healthcare | $17.29 | 2025 | |
| Axonics, INC. | $16.65 | 2023 | Axonics |
| Calyxo, INC. | $15.36 | 2023 | Cvac Aspiration System |
| Tolmar, INC. | $14.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eihab Akary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.